According to a new study, older workers are half has likely to take sick leave as compared to their younger counterparts.
The research by an insurance company found that those in their 20's are twice as likely to take sick leaves when compared to their older colleagues.Just a quarter of the workers above the age of 50 years needed sick leaves in the previous year compared to half of those in the age group of 20 to 29 years, according to RIAS insurance firm.
Peter Corfield, managing director of insurance company RIAS, said, "Over-50s workers continue to be a vital part of the British workforce and they should be recognised for the contribution they make. They bring a wealth of experience, ambition and knowledge that cannot be overestimated.It is key that we understand that workers in their 50s and 60s are not old, they are hard-working and dedicated, and very much want to work."
Corfield also said that hiring mature people will help UK businesses to save money lost in sick leaves.
The study also showed that 10 per cent of over-50s said that they took more time than required on offs compared to 55 per cent of those in the age group of 20 to 39 years. About 44 per cent of younger people pretended to be ill to have a day off compared to just 12 per cent for those above the age of 50 years.
In a recently published blog post, "social media theorist" and Snapchat researcher Nathan Jurgenson has revealed that Snapchat is funding a new online magazine called 'Real Life.'
In announcing that Snapchat is bankrolling the new 'Real...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recently published blog post, "social media...
With tech giant Google scheduled to launch the Play...
Monohm Inc.’s incredibly weird circular smartphone-cum-...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).